SCHEMBL2225663

SCHEMBL2225663

COc1cc(Nc2cc(NCc3cccc(S(N)(=O)=O)c3)ncn2)cc(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.59
ERBB3 P21860 3/20 0.59
CCNT1 O60563 2/20 0.52
CDK9 P50750 2/20 0.52
TNNI3K Q59H18 3/20 0.51
FGFR1 P11362 1/20 0.46
MAP4K4 O95819 1/20 0.45
CDK1 P06493 1/20 0.45
CDK4 P11802 1/20 0.45
CCNB1 P14635 1/20 0.45
CCNA2 P20248 1/20 0.45
CCND1 P24385 1/20 0.45
CDK2 P24941 1/20 0.45
ABL2 P42684 1/20 0.45
GSK3A P49840 1/20 0.45
CDK7 P50613 1/20 0.45
CCNH P51946 1/20 0.45
MNAT1 P51948 1/20 0.45
CCNA1 P78396 1/20 0.45
CDK5 Q00535 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225795 0.81 NTRK1 (0.46) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL2226983 0.81 CA1 (0.46) EGFRERBB3MEN1KMT2ACYP1A2
SCHEMBL2224438 0.81 TNNI3K (0.57) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL2225416 0.81 NTRK1 (0.56) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL2226138 0.81 TNNI3K (0.57) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL2224279 0.80 EGFR (0.53) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL2228327 0.80 CYP1A2 (0.52) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL2224431 0.79 EGFR (0.49) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL2225667 0.78 JAK1 (0.47) EGFRERBB3CCNT1CDK9TNNI3K
SCHEMBL4760653 0.78 CYP2D6 (0.71) CCNT1CDK9MAP4K4CDK1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed